Friday, November 29, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
Psychedelic Stock Review

Psycheceutical Bioscience Inc.’s (BWVI) Novel Topical Ketamine Delivery.

Editor / Curator -
ARDX, Roland Rick Perry
2022 Watch List

And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%.

Editor / Curator -
2022 Watch List

Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.

Editor / Curator -
Alternative Energy

Updating Coverage Report: Two Binary Events Rapidly Approaching Principal Solar (PSWW).

Editor / Curator -
Featured

Hidden Gem and a Monster in the Making? Beasley Broadcast Group...

Editor / Curator -
2023 Watch List

Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for...

Editor / Curator -
Incubator

Smart for Life (SMFL) Reports Revenue Increases 96.9% to $17.8 Million...

Editor / Curator -
Marijuana Stock Review

Adding Vext Science (VEXTF) $0.17 to the Watch List.

Editor / Curator -
Incubator

Report: Think Equity Updates Society Pass (SOPA). $6.00 Price Target.

Editor / Curator -
Alternative Energy

IA Initiates Analyst Coverage of Principal Solar (Press Release).

Editor / Curator -
1...181920...93Page 19 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.